Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Sacubitril-Valsartan in Heart Failure With Preserved Ejection Fraction and Secondary Mitral Valve Regurgitation

NCT05991284 is registered in ClinicalTrials.gov with Ziekenhuis Oost-Limburg as lead sponsor.

NCT NCT05991284
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05991284 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Sacubitril-Valsartan in Heart Failure With Preserved Ejection Fraction and Secondary Mitral Valve Regurgitation
Lead sponsor
Ziekenhuis Oost-Limburg
Phase
Phase 4
Overall status
Completed
Start date
February 29, 2024
Completion date
May 9, 2026
Enrollment
84 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

functional mitral regurgitation, heart failure with preserved ejection fraction